KCAS Bio

KCAS Bio is a top-tier contract research organization (CRO) that has 45 years of experience with both large pharma and biotech sponsors, providing comprehensive bioanalytical drug development services from early discovery through registration.

We have provided bioanalytical support for more than 315 approved drugs on the market, developed 6,200+ proprietary and non-proprietary assays to date, and successfully completed more than 20 FDA audits with no major findings.

Our presence in multiple locations throughout the US and Europe - and with a strategic alliance in Australia - allows us to serve sponsors globally with bioanalytical, biomarker, immunogenicity, cellular and molecular assay services along with clinical kitting and sample management.

With the expertise, capacity and flexibility sponsors require, we can fulfill our purpose, which is to help accelerate the discovery and development of life-changing drugs smoothly, safely and sustainably.